2002
DOI: 10.1128/aac.46.2.500-510.2002
|View full text |Cite
|
Sign up to set email alerts
|

Genes Encoding TEM-4, SHV-2, and CTX-M-10 Extended-Spectrum β-Lactamases Are Carried by MultipleKlebsiella pneumoniaeClones in a Single Hospital (Madrid, 1989 to 2000)

Abstract: Over a 12-year period (1989 to 2000), 159 Klebsiella pneumoniae isolates harboring extended-spectrum ␤-lactamases (ESBLs) (4.8% of the total number of K. pneumoniae isolates obtained) were recovered from 58 patients, who were mainly hospitalized in intensive care and surgery units. For 62 representative isolates from 58 patients, 31 clonal types harboring TEM-4 (n ‫؍‬ 5), SHV-2 (n ‫؍‬ 7), SHV2a (n ‫؍‬ 4), SHV-5 (n ‫؍‬ 1), CTX-M-10 (n ‫؍‬ 13), or CTX-M-9 (n ‫؍‬ 1) ␤-lactamases were identified by pulsed-field ge… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

6
125
2
4

Year Published

2003
2003
2020
2020

Publication Types

Select...
4
4

Relationship

0
8

Authors

Journals

citations
Cited by 184 publications
(137 citation statements)
references
References 43 publications
(61 reference statements)
6
125
2
4
Order By: Relevance
“…The first organisms producing ␤-lactamases of this type were identified both as single and epidemic clinical isolates in very distant geographic regions (Germany and France and Argentina) in the early 1990s (3, 5, 7). More recently, a rapid increase in the proportion of multiple CTX-M variants to the TEM-and SHV-derived ESBLs has been reported in many hospitals in Spain (9,12,15,35) (14), and Korea (28). Furthermore, CTX-M ␤-lactamases, mainly types CTX-M-2 and CTX-M-3, were found to be widespread or even predominant ESBL types in several countries, including Argentina (31, 34; M. Galas, F. Pasteran, R. Melano, A. Petroni, G. Lopez, A. Corso, A. Rossi, et al, Abstr.…”
mentioning
confidence: 99%
“…The first organisms producing ␤-lactamases of this type were identified both as single and epidemic clinical isolates in very distant geographic regions (Germany and France and Argentina) in the early 1990s (3, 5, 7). More recently, a rapid increase in the proportion of multiple CTX-M variants to the TEM-and SHV-derived ESBLs has been reported in many hospitals in Spain (9,12,15,35) (14), and Korea (28). Furthermore, CTX-M ␤-lactamases, mainly types CTX-M-2 and CTX-M-3, were found to be widespread or even predominant ESBL types in several countries, including Argentina (31, 34; M. Galas, F. Pasteran, R. Melano, A. Petroni, G. Lopez, A. Corso, A. Rossi, et al, Abstr.…”
mentioning
confidence: 99%
“…Beispielhaft dafür sind Ergebnisse aus einem spanischen Krankenhaus. Hier traten ESBL der Typen TEM-4, SHV-2 und CTX 10 in genotypisch verschiedenen Stämmen der Spezies E. coli und K. pneumoniae auf [29].…”
Section: Auswahl Von Antibiotika Für Die Resistenzbestimmungunclassified
“…The disc-inserted plates were incubated at 37ºC for 18-24 h. The zones of inhibition was evaluated according to the criteria by CLSI (2013) [16,17] . A difference of ≥5 mm between the zone measurements of the identical discs ± CV were considered to be ESBL-producing species [15,17,18] .…”
Section: Disc Diffusion Confirmation Testmentioning
confidence: 99%
“…The isolate was spiked in a sterile saline physiological solution to get a density expressed as 0.5 McFarland standard. Using a cotton swap, it was spreaded over Mueller Hinton Agar (MHA) (Merck, Germany) [15,16] . The ESBL screening was performed by cefotaxime (CTX; 30 μg), ceftazidime (CAZ; 30 μg), and cefpodoxime (CPD; 10 μg) discs (TurkLab, Turkey).…”
Section: Screening and Confirmation Of Esbls Disc Diffusion Testingmentioning
confidence: 99%